Contraceptive pill and gonadotropin-releasing hormone (GnRH) flare-up agonist versus GnRH antagonist protocol in poor responders: Lessons to a prospective study

Florence Scheffler (1) , P. Merviel (2, 3) , E. Lourdel , Rosalie Cabry (1, 4) , A. Devaux (5) , Moncef Ben Khalifa (4, 1) , N. Mansouri (6) , Noémie Celton (4) , H. Copin (7)

1 PERITOX - Périnatalité et Risques Toxiques - UMR INERIS_I 1
2 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale
3 BREST - Gynéco-Obs - Service de Gynécologie-Obstétrique
4 CHU Amiens-Picardie
5 Aubert & Duval
6 ECS
7 Laboratoire de Cytogénétique

Mots clés: IVF; poor responder; GnRH agonist; GnRH antagonist; pregnancy rate

Domaines: Sciences du Vivant [q-bio]

Florence Scheffler, P. Merviel, E. Lourdel, Rosalie Cabry, A. Devaux, et al.. Contraceptive pill and gonadotropin-releasing hormone (GnRH) flare-up agonist versus GnRH antagonist protocol in poor responders: Lessons to a prospective study. Human Reproduction, 2015, 30 (1), pp.295. ⟨hal-03549133⟩